Navigation Links
BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
Date:5/19/2009

ARLINGTON, Va., May 19 /PRNewswire/ -- BioInformatics, LLC (http://www.gene2drug.com) -- the leading market research and advisory firm serving the life science industry -- announces the publication of its latest report, "The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III." Given the highly fragmented nature of the pre-made catalog antibodies market, this report is designed to create opportunities for differentiation by providing suppliers with an in-depth knowledge of scientists' expectations and preferences as regards to selection, availability, delivery time, pricing and supplier/brand.

The report is scheduled to release at the end of May, and pre-release pricing ends on May 29, 2009.

As part of BioInformatics LLC's ongoing monitoring of the antibodies market, the 2009 report facilitates tracking changes in the market that have occurred since the publication of the 2006 version. Perhaps the most significant change is Abcam's (ABC.L: LSE) leap from an estimated market share of 5.2% in 2006 to 10% in 2009, trailing the market leader, Santa Cruz Biotechnology by only 2.5%. Additionally, Abcam and Cell Signaling Technology were selected by scientists as the suppliers providing the best overall antibody quality and customer service. Abcam's commitment to product quality has enabled them to directly challenge the positions of Sigma Aldrich (Nasdaq: SIAL), Life Technologies (Nasdaq: LIFE) and Millipore (NYSE: MIL).

"In a fragmented market suppliers have the option of competing broadly or focusing on a few select areas," notes Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services. "Regardless of which strategy antibody suppliers pursue, this report highlights the key success factors that will enable companies to compete and win market share."

For a complimentary Executive Summary of this report, please visit http://www.gene2drug.com/report/202/

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 43,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

    For more information, please contact:

    Mary Follin
    Manager, Marketing/Sales
    BioInformatics, LLC
    2111 Wilson Blvd., Suite 250
    Arlington, VA  22201
    703.778.3080 x13 (phone)
    m.follin@gene2drug.com
   http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
2. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
3. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
4. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):